Answers are grounded in this paper and cite their sources.
Real-world data suggests that NICT could be a favorable treatment option compared with PCT for patients with advanced NSCLC. Further follow-up is needed to determine the long-term prognostic benefit.
No takes yet. Share an insight, caveat, or question.
Matsumoto et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: